Individual generic drugmakers, including Mylan and Teva, were urged to step up their lobbying efforts at the leading generic drug trade group's meeting, according to Bloomberg Law.
Pharmacy
Walgreens will pay about $2 million to resolve two lawsuits alleging it overcharged the Massachusetts Medicaid program and falsified information on some of the reimbursement claims, according to The Berkshire Eagle.
The Senate Finance Committee on Feb. 4 invited seven CEOs from major drug companies to testify at a hearing about high prescription drug costs later this month. So far, four of the companies have agreed to send their executives to…
GlaxoSmithKline and Merck have partnered to develop and commercialize a cancer immunotherapy treatment in a deal that could be valued at $4.2 billion, Bloomberg reports.
Hedge fund Appaloosa LP is placing more pressure on Allergan to separate the roles of chairman and CEO in an effort to address the drugmaker's underperformance.
Advertisement
ProvideGx, a company established by Premier in January to address generic drug shortages, will start with manufacturing a blood pressure medication that has been hard to obtain.
PillPack, the online pharmacy startup purchased by Amazon last year, has obtained nine additional state pharmacy licenses in the last two months, according to Med City News.
Rochester, Minn.-based Mayo Clinic's planned $8 million pharmacy will primarily focus on mail-order prescriptions and will not be used for public use, according to the Post Bulletin.
The Pistoia Alliance, a nonprofit alliance focused on driving research and development efforts in the life sciences industry, launched the next phase of its blockchain project Feb. 6.
Chicago-based Novum Pharma filed for Chapter 11 bankruptcy Feb. 1, and plans to sell its assets, according to The Wall Street Journal.